NO20005062L - Behandling av panikkanfall - Google Patents

Behandling av panikkanfall

Info

Publication number
NO20005062L
NO20005062L NO20005062A NO20005062A NO20005062L NO 20005062 L NO20005062 L NO 20005062L NO 20005062 A NO20005062 A NO 20005062A NO 20005062 A NO20005062 A NO 20005062A NO 20005062 L NO20005062 L NO 20005062L
Authority
NO
Norway
Prior art keywords
panic attacks
treatment
panic
attacks
isobenzo
Prior art date
Application number
NO20005062A
Other languages
English (en)
Norwegian (no)
Other versions
NO20005062D0 (no
Inventor
Connie Sanchez
Sandra Hogg
Maria Jessa
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20005062D0 publication Critical patent/NO20005062D0/no
Publication of NO20005062L publication Critical patent/NO20005062L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20005062A 1998-04-07 2000-10-06 Behandling av panikkanfall NO20005062L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK50198 1998-04-07
PCT/DK1999/000190 WO1999051229A1 (en) 1998-04-07 1999-03-30 Treatment of panic attacks

Publications (2)

Publication Number Publication Date
NO20005062D0 NO20005062D0 (no) 2000-10-06
NO20005062L true NO20005062L (no) 2000-11-30

Family

ID=8094284

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005062A NO20005062L (no) 1998-04-07 2000-10-06 Behandling av panikkanfall

Country Status (23)

Country Link
US (1) US6262061B1 (sh)
EP (1) EP1069899A1 (sh)
JP (1) JP2002510626A (sh)
KR (1) KR20010042502A (sh)
CN (1) CN1296409A (sh)
AR (1) AR019023A1 (sh)
AU (1) AU3025899A (sh)
BG (1) BG104814A (sh)
BR (1) BR9909598A (sh)
CA (1) CA2325948A1 (sh)
EA (1) EA200001032A1 (sh)
HR (1) HRP20000659A2 (sh)
HU (1) HUP0101706A3 (sh)
ID (1) ID28335A (sh)
IL (1) IL138484A0 (sh)
IS (1) IS5636A (sh)
NO (1) NO20005062L (sh)
PL (1) PL342989A1 (sh)
SK (1) SK14842000A3 (sh)
TR (1) TR200002891T2 (sh)
WO (1) WO1999051229A1 (sh)
YU (1) YU58900A (sh)
ZA (1) ZA200004856B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK3502001A3 (en) * 1998-09-15 2001-12-03 Lundbeck & Co As H Use of 1'-[4-[1-(4-fluorophenyl)-1h-indole-3-yl]-1-butyl]- spiro[isobenzofuran-1(3h),4'-piperidine] for the treatment of depression
AU2001279607A1 (en) * 2000-08-15 2002-02-25 H. Lundbeck, A/S Pharmaceutical composition containing 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl) -1-butyl)-spiro(isobenzofuran-1(3h),4'-piperidine)
WO2004110387A2 (en) * 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0101706A3 (en) 2003-03-28
BR9909598A (pt) 2000-11-21
HRP20000659A2 (en) 2001-04-30
KR20010042502A (ko) 2001-05-25
ZA200004856B (en) 2001-08-29
AU3025899A (en) 1999-10-25
IS5636A (is) 2000-09-22
TR200002891T2 (tr) 2001-02-21
CA2325948A1 (en) 1999-10-14
NO20005062D0 (no) 2000-10-06
PL342989A1 (en) 2001-07-16
YU58900A (sh) 2002-11-15
ID28335A (id) 2001-05-10
SK14842000A3 (sk) 2001-06-11
JP2002510626A (ja) 2002-04-09
HUP0101706A2 (hu) 2001-11-28
CN1296409A (zh) 2001-05-23
AR019023A1 (es) 2001-12-26
WO1999051229A1 (en) 1999-10-14
IL138484A0 (en) 2001-10-31
EP1069899A1 (en) 2001-01-24
BG104814A (en) 2001-04-30
US6262061B1 (en) 2001-07-17
EA200001032A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
PT1083899E (pt) Derivados de 1-desoxi-galactonojirimicina e respectiva utilização no tratamento de doenças de acumulação lisossomal, por intensificação da alfa-galactosidase a lisossomal
ATE154239T1 (de) Sphäroidische arzneimittelformulierung
ATE114118T1 (de) System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren.
CA2149636A1 (en) Method of activating photosensitive agents
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
AU2002241719A1 (en) Therapy management techniques for an implantable medical device
MY108496A (en) Hypoglycemic thiazolidine diones.
DE69535349D1 (de) Implantierbare aktive medizinische Vorrichtung mit Mittel zur Unterscheidung zwischen Ruhe- bzw. Aktivzustand des Patienten
FR2739782B1 (fr) Dispositif medical implantable actif, notamment stimulateur cardiaque, a fonctionnement asservi et consommation reduite
NO904839L (no) Fremgangsmaate for fremstilling av benzoxazinderivater.
DE69331605T2 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
AU7239996A (en) Inhibition of tumor necrosis factor alpha
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
AU4409489A (en) Animal model for diagnosing and testing vaccines or therapeutic agents against aids
TR200001267T2 (tr) 1'-[4-Florofenil)-1H-Indol-3-İl] -1-Bütil1-Spiro[izobenzofüran- 1(3H), 4'-Piperidin] hidrohalojenitler
NO20005062L (no) Behandling av panikkanfall
AU7267091A (en) Derivatives of 4-(aminomethyl)piperidine, their preparation and their therapeutic application
NO982863L (no) Nye forbindelser med analgetisk effekt
CA2097182A1 (en) Method and device for treating tobacco addiction
NO20011268L (no) Forbindelse til behandling av depresjon
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.
Malec et al. A clinical trial of the combination of L-tryptophan and lithium in the treatment of chronic alcoholism.
UA49165A (uk) Спосіб лікування фонових процесів шийки матки хламідійної етіології
UA31474A (uk) Спосіб зняття потягу до алкоголю

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application